Sun Pharmaceuticals Industries Ltd.
BSE: 524715 | Sector: Health care |
NSE: SUNPHARMA | ISIN Code: INE044A01036 |
BSE 12:39 | 28 Jun | 829.80 |
-6.15 (-0.74%) |
OPEN
835.95 |
HIGH
836.00 |
LOW
827.00 |
NSE 12:29 | 28 Jun | 830.90 |
-4.75 (-0.57%) |
OPEN
837.00 |
HIGH
837.50 |
LOW
826.95 |
OPEN | 835.95 |
PREVIOUS CLOSE | 835.95 |
VOLUME | 13225 |
52-Week high | 966.90 |
52-Week low | 664.10 |
P/E | |
Mkt Cap.(Rs cr) | 199,094 |
Buy Price | 829.80 |
Buy Qty | 199.00 |
Sell Price | 830.10 |
Sell Qty | 46.00 |
Sun Pharmaceuticals Industries Ltd. (SUNPHARMA) - Net Profit
Net Profit
COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Profit (Rs crore) |
Aurobindo Pharma | 512.85 | -8.45 | -1.62 | 3112.91 |
Cipla | 931.05 | -1.20 | -0.13 | 2468.28 |
Dr Reddy's Labs | 4335.60 | 18.45 | 0.43 | 2186.40 |
Sun Pharma.Inds. | 829.80 | -6.15 | -0.74 | 2139.70 |
Divi's Lab. | 3606.35 | -67.15 | -1.83 | 1954.72 |
Alkem Lab | 3000.10 | -32.30 | -1.07 | 1685.08 |
Glenmark Pharma. | 386.50 | 0.05 | 0.01 | 1649.45 |
Zydus Lifesci. | 353.35 | -0.55 | -0.16 | 1476.20 |
Lupin | 633.05 | 3.15 | 0.50 | 1258.62 |
Alembic Pharma | 744.40 | -4.55 | -0.61 | 1175.39 |
Ipca Labs. | 915.60 | 3.75 | 0.41 | 1140.77 |
Torrent Pharma. | 2849.00 | -11.60 | -0.41 | 1137.85 |
Gland Pharma | 2628.50 | -30.10 | -1.13 | 997.01 |
Sanofi India | 6401.00 | -35.75 | -0.56 | 944.40 |
Laurus Labs | 467.40 | 0.35 | 0.07 | 750.09 |
Abbott India | 18018.00 | 26.80 | 0.15 | 690.69 |
Ajanta Pharma | 1253.05 | -10.90 | -0.86 | 675.64 |
Wockhardt | 212.85 | -8.20 | -3.71 | 593.29 |
Granules India | 275.00 | 7.10 | 2.65 | 552.78 |
Pfizer | 4106.50 | 1.50 | 0.04 | 497.61 |
Quick Links for Sun Pharmaceuticals Industries:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices